Sinopharm Tech Holdings Limited reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported sales was HKD 26.2 million compared to HKD 12.92 million a year ago. Net loss was HKD 9.91 million compared to HKD 17.24 million a year ago. Basic loss per share from continuing operations was HKD 0.0022 compared to HKD 0.004 a year ago.
For the nine months, sales was HKD 37.93 million compared to HKD 68.12 million a year ago. Net loss was HKD 23.41 million compared to HKD 31.38 million a year ago. Basic loss per share from continuing operations was HKD 0.0052 compared to HKD 0.0073 a year ago.